药学研究
藥學研究
약학연구
JOURNAL OF PHARMACEUTICAL RESEARCH
2014年
8期
485-487
,共3页
通痹胶囊%类风湿性关节炎%寒湿阻络证%肝肾两虚证
通痺膠囊%類風濕性關節炎%寒濕阻絡證%肝腎兩虛證
통비효낭%류풍습성관절염%한습조락증%간신량허증
Tongbi CaPsules%Rheumatoid arthritis%Syndrome of cold - damPness blocking collaterals%Syndrome of deficiency of liver and kidney
目的：观察通痹胶囊治疗类风湿关节炎的临床疗效。方法随机入选病例410例，试验组308例，口服通痹胶囊，1粒/次，2~3次/日；对照组102例，口服壮骨关节丸，6 g/次，2次/日，60 d为1个疗程。结果治疗后，试验组的疾病疗效与中医证候疗效总有效率分别为89.78%、90.51%，与对照组比较，有统计学差异（ P ＜0.05）。结论通痹胶囊临床用于治疗类风湿性关节炎（寒湿阻络、肝肾两虚型痹证）安全、有效。
目的：觀察通痺膠囊治療類風濕關節炎的臨床療效。方法隨機入選病例410例，試驗組308例，口服通痺膠囊，1粒/次，2~3次/日；對照組102例，口服壯骨關節汍，6 g/次，2次/日，60 d為1箇療程。結果治療後，試驗組的疾病療效與中醫證候療效總有效率分彆為89.78%、90.51%，與對照組比較，有統計學差異（ P ＜0.05）。結論通痺膠囊臨床用于治療類風濕性關節炎（寒濕阻絡、肝腎兩虛型痺證）安全、有效。
목적：관찰통비효낭치료류풍습관절염적림상료효。방법수궤입선병례410례，시험조308례，구복통비효낭，1립/차，2~3차/일；대조조102례，구복장골관절환，6 g/차，2차/일，60 d위1개료정。결과치료후，시험조적질병료효여중의증후료효총유효솔분별위89.78%、90.51%，여대조조비교，유통계학차이（ P ＜0.05）。결론통비효낭림상용우치료류풍습성관절염（한습조락、간신량허형비증）안전、유효。
Objective The effect of Tongbi CaPsules on rheumatoid arthritis( RA)was observed in this PaPer. Meth-ods 410 Patients were randomly divided into treated grouP and control grouP. 308 Patients in treated grouP took one Tongbi CaPsules each time,two or three times Per day. While 102 Patients in control grouP were treated routinely with Zhuanggu Guanjie Pills,6 g for one time,twice a day with a course of sixty days in two grouPs. Results After a course of treatment, the total clinical effective rate and the rate of imProvement of traditional Chinese medical syndrome was 89. 78% and 90.51%,resPectively. Statistically,the difference between two grouPs was significant(P <0.05). Conclusion Tongbi CaPsules was effective and safe in the treating for rheumatoid arthritis( syndrome of cold-damPness blocking collaterals, syndrome of deficiency of liver and kidney).
